What Is Cardiac Monitoring and How Does It Work?

Cardiac monitoring is the continuous or intermittent recording of your heart’s electrical activity, and sometimes its pressures and rhythms, to detect abnormalities that a single snapshot might miss. At its core, the technology works by placing sensors on or inside the body that pick up the tiny electrical signals your heart produces with every beat. Those signals are amplified, filtered, and displayed as the familiar wavy line of an electrocardiogram (ECG). But the landscape of cardiac monitoring now stretches far beyond the bedside ECG machine, spanning adhesive patches you wear for weeks, implanted devices that sit under your skin for years, and smartwatches that check your rhythm from your wrist.

How Your Heart Produces a Readable Signal

Every heartbeat begins with a small burst of electrical activity in a cluster of cells near the top of the heart. That impulse spreads in an organized wave through the heart muscle, causing the chambers to contract and push blood forward. The electrical current doesn’t stay contained within the heart. It radiates outward through surrounding tissue and reaches the skin, where electrodes can detect it. The voltage is small, typically measured in millivolts, but it’s enough for modern sensors to capture reliably.

These electrical signals are the raw material for virtually every form of cardiac monitoring. Electrodes placed on the chest, limbs, or even the wrist collect the voltage changes over time, producing a tracing that clinicians read for rhythm, rate, and signs of damage or stress.¹ The shape and timing of each wave on the ECG tells a specific story: whether the upper chambers fired first, whether the signal traveled through the normal pathway, whether part of the muscle is starved for oxygen, and more.

The Standard ECG and In-Hospital Telemetry

The most familiar form of cardiac monitoring is the 12-lead ECG, where ten electrodes are placed on your chest and limbs to record the heart’s electrical activity from twelve different angles simultaneously. This test takes about ten seconds and gives a detailed picture of what your heart is doing at that exact moment. It’s the first tool doctors reach for when someone arrives with chest pain, shortness of breath, or a racing heart.

The limitation is obvious: a ten-second recording only catches problems that happen to be occurring right then. Many dangerous arrhythmias come and go. That’s where in-hospital telemetry comes in. If you’re admitted to a hospital for a cardiac concern or recovering from surgery, you may be connected to a continuous monitoring system. Small wireless electrodes on your chest transmit your heart rhythm in real time to a central station, where technicians and nurses watch for concerning changes.

Telemetry plays a vital role in catching arrhythmias and can help predict serious events like cardiac arrest or sepsis.² However, it comes with a well-known problem: alarm fatigue. An overwhelming majority of the alarms that telemetry systems generate turn out to be clinically unimportant, with estimates placing the false or non-actionable alarm rate between 80% and 99%.³ When nurses are bombarded with hundreds of meaningless beeps per shift, they can become desensitized and potentially miss the alarm that actually matters. Hospitals are actively working on smarter alarm thresholds and triage algorithms to address this.

Ambulatory Monitoring Outside the Hospital

Most heart rhythm problems don’t perform on cue. A person might feel their heart skip or race once a week, or once a month, with perfectly normal rhythm the rest of the time. Ambulatory monitors are designed to catch those intermittent events by extending the recording period from seconds to days or weeks.

Holter Monitors

The Holter monitor is the classic outpatient option. It’s a small, battery-powered device attached to several electrode patches on your chest, and it records every heartbeat continuously for 24 to 48 hours. You go about your normal routine, pressing a button if you feel symptoms so the technician can correlate your diary with what the tracing shows. Holter monitors are widely available and well understood, but a day or two of recording simply isn’t enough time for many arrhythmias to show up.

Extended Patches and Event Monitors

Adhesive ECG patches have changed the game considerably. These are thin, lightweight devices that stick directly to your chest and can record continuously for a week or two, requiring no wires or separate recorder box. The difference in detection rates is striking. In one comparison, a 14-day ECG patch caught intermittent arrhythmias in about two-thirds of patients, while the standard 24-hour Holter caught them in fewer than one in ten.⁴ A separate study comparing 7-day patches to 24-hour Holters found a similar pattern, with the longer monitoring period roughly doubling the overall arrhythmia detection rate.⁵

Event monitors take a slightly different approach. Rather than recording everything, some event monitors only save the heart rhythm when triggered, either by the patient pressing a button during symptoms or by an automatic algorithm that detects an abnormal rhythm and stores the surrounding data. More advanced loop recorders continuously overwrite a short buffer of ECG data, keeping only the segments around a triggered event. Modern versions can transmit these captured episodes wirelessly to a physician for real-time review.⁶ A practical downside is that patients sometimes fail to activate the device, particularly people who live alone or aren’t comfortable with the technology.

Implantable Loop Recorders

When arrhythmias are suspected but occur so rarely that even two weeks of external monitoring isn’t enough, physicians may recommend an implantable loop recorder (ILR). This is a tiny device, roughly the size of a USB flash drive, that a cardiologist places just under the skin of the chest through a small incision. It continuously monitors your heart rhythm and can store data for up to three years.

ILRs are primarily used for people with unexplained fainting episodes, palpitations that defy other testing, and to search for atrial fibrillation after a stroke that has no other obvious cause.⁷ In patients with unexplained syncope, the ILR frequently finds the answer. One study of over a hundred such patients found that about one in five eventually received a pacemaker based on the slow-heart-rate episodes the ILR documented, with the median time from implant to diagnosis being roughly 81 days.⁸ Without the extended monitoring window, many of those patients would have continued having unexplained blackouts.

Why Longer Monitoring Catches More

The recurring theme across monitoring technologies is that time matters enormously. Atrial fibrillation is a perfect example. It’s the most common serious arrhythmia and a major risk factor for stroke, but it often occurs in brief, self-terminating bursts that can easily dodge a 24-hour Holter. Evidence strongly suggests that extending monitoring beyond a single day increases detection rates, and after a cryptogenic stroke specifically, guidelines increasingly recommend at least 72 hours of monitoring, though even longer periods yield further gains.⁹

A randomized trial of home-based continuous ECG patches found that among people newly diagnosed with atrial fibrillation during monitoring, the median time to first detection was two days, though some cases weren’t caught until much later in the monitoring window.¹⁰ This is why the trend in cardiac monitoring has been moving consistently toward longer, less intrusive recording periods.

Consumer Smartwatches and Wrist-Based Monitoring

Perhaps the most visible shift in cardiac monitoring over the past decade is the arrival of consumer smartwatches capable of recording an ECG or flagging irregular rhythms. Devices from Apple, Samsung, Withings, and others now offer some form of heart rhythm analysis directly from the wrist, using either optical sensors that detect blood-flow changes or small electrical sensors built into the watch case.

The accuracy is better than many clinicians initially expected. A systematic review and meta-analysis pooling data from 26 studies and over 17,000 patients found that smartwatches overall achieved about 95% sensitivity and 97% specificity for detecting atrial fibrillation.¹¹ Performance varied somewhat by brand: the Apple Watch showed about 94% sensitivity and 97% specificity, Samsung devices came in at roughly 97% sensitivity and 96% specificity, and the Withings ScanWatch had about 89% sensitivity with 95% specificity. A separate meta-analysis focusing on the Apple Watch specifically reported similar numbers and found that smartwatch-based detection was statistically comparable to traditional ECG and Holter monitoring strategies for finding atrial fibrillation.¹²

That said, these devices have clear boundaries. They are screening tools, not diagnostic ones. A smartwatch notification of irregular rhythm needs to be confirmed with a clinical-grade ECG before any treatment decisions are made. Wrist-based heart rate measurements from optical sensors can also drift under certain conditions, particularly during vigorous exercise or if the watch shifts on the wrist. Studies comparing optical-sensor heart rate to simultaneous Holter recordings have found strong overall agreement, but with limits of agreement wide enough that individual readings can be off by a meaningful amount.

Cleaning Up the Signal

Raw electrical recordings from the heart are rarely pristine. Muscle movements, breathing, loose electrodes, and electrical interference from nearby equipment all introduce noise that can obscure the underlying heart signal. Before a clinician or algorithm can interpret an ECG, the recording needs to be filtered.

The main sources of noise each have different characteristics and require different filtering strategies. Baseline wander is a slow, rolling drift in the ECG trace caused by breathing or body movement. Motion artifacts are sharper disruptions from physical movement. Electrode motion noise comes from the electrode shifting on the skin. Power-line interference creates a characteristic hum from surrounding electronics.¹³ Modern filtering systems increasingly use machine learning to first identify which type of noise is present, then apply the appropriate filter selectively rather than using a one-size-fits-all approach.¹⁴

Signal quality is more than a technical nuisance. When noise is severe enough, it can mimic dangerous arrhythmias on the ECG tracing, potentially leading to unnecessary treatments. Conversely, dismissing a real arrhythmia as artifact can be equally harmful. The challenge of distinguishing true cardiac events from noise-generated lookalikes remains one of the persistent difficulties in cardiac monitoring, whether the tracing comes from a hospital telemetry system or a consumer wearable.

AI and Automated Interpretation

The sheer volume of data that continuous monitoring generates makes manual review impractical. A 14-day patch records over a million heartbeats. Multiply that across hundreds of patients in a clinic’s monitoring pipeline, and you quickly reach a point where human reviewers can’t keep up. This is where automated interpretation steps in.

Deep learning algorithms have become the dominant approach for automated ECG analysis, consistently outperforming older rule-based and traditional machine learning methods for arrhythmia detection.¹⁵ These systems are trained on large databases of labeled ECGs to recognize patterns associated with different arrhythmias. More recent work has pushed toward not just detecting arrhythmias but predicting their recurrence, such as forecasting which patients are likely to have atrial fibrillation come back after treatment.¹⁶

Importantly, AI-based ECG tools are increasingly being designed with explainability in mind, meaning the algorithm can highlight which portion of the ECG tracing led to its conclusion rather than simply outputting a label. This matters because clinicians are understandably reluctant to act on a diagnosis if the reasoning behind it is a black box.

Beyond Electrical Signals

Not all cardiac monitoring tracks the heart’s electrical activity. Some of the most impactful advances involve monitoring hemodynamics, meaning the pressures and flows inside the heart and blood vessels. For people with chronic heart failure, a small sensor implanted in the pulmonary artery can wirelessly transmit pressure readings to their care team every day. When pressures start to climb, it’s an early warning that fluid is building up and heart failure is worsening, often days before the patient would feel sick enough to go to the hospital.

A randomized trial of this approach in patients with moderate-to-severe heart failure found that pulmonary artery pressure monitoring substantially improved quality of life and reduced hospitalizations compared to standard care.¹⁷ This represents a fundamentally different use case from rhythm monitoring: instead of waiting for an arrhythmia to strike, the system provides a continuous picture of how the heart is performing as a pump, enabling preemptive medication adjustments.

Fetal Cardiac Monitoring

Cardiac monitoring isn’t limited to adults. During pregnancy, fetal heart monitoring is used to assess the baby’s heart rate and rhythm, both during routine prenatal visits and especially during labor. The most common method uses an external ultrasound transducer placed on the mother’s abdomen, which detects the fetal heartbeat through Doppler technology rather than electrical signals.

A more specialized technique involves non-invasive fetal electrocardiography, where electrodes on the mother’s abdomen attempt to pick up the baby’s ECG signal. This is technically challenging because the fetal signal is buried within a mix of the mother’s own, much larger cardiac signal and various sources of noise. Extracting it requires sophisticated filtering to separate the fetal ECG component from the maternal ECG and background interference.¹⁸ When successful, though, fetal ECG provides more detailed information about the baby’s heart rhythm than Doppler alone.

Data Integration and Security Challenges

Modern cardiac monitoring increasingly lives in a connected ecosystem. Wearable patches transmit data to cloud platforms. Smartwatches sync to phone apps. Implanted devices upload readings through bedside transmitters. Hospital telemetry feeds into electronic medical records. This connectivity enables remote monitoring, where a care team can review your heart data without requiring an office visit, and some health systems are experimenting with dashboard-based triage that flags deviations from a patient’s own baseline rather than relying on fixed thresholds.¹⁹

But connectivity comes with risk. Any medical device that transfers data wirelessly is potentially exposed to cybersecurity threats. Concerns range from unauthorized access to patient health data to the more alarming (though so far largely theoretical) possibility of interfering with implanted device function.²⁰ Manufacturers and health systems have responded with encryption, authentication protocols, and regulatory oversight, but the expanding attack surface of connected cardiac devices is a concern that grows alongside the technology itself.

The practical bottleneck, for now, is arguably less dramatic than hacking. Wearable devices generate massive, messy datasets with gaps from when the device wasn’t worn, artifact-heavy segments, and sheer volume that can overwhelm clinical workflows. Getting useful, actionable clinical information out of that fire hose of raw data remains one of the bigger unsolved challenges in digital cardiology.

The Psychological Side of Being Monitored

One dimension of cardiac monitoring that doesn’t get enough attention is what it does to the person wearing the device. Being continuously reminded that your heart might do something dangerous can take a psychological toll. A scoping review of wearable device use in cardiac patients identified four categories of negative psychological effects: heightened health anxiety, repeated reassurance-seeking triggered by device alerts, excessive self-monitoring and device dependence, and reduced confidence in self-managing their condition.²¹

A study focused specifically on atrial fibrillation patients found that wearable users reported greater preoccupation with symptom monitoring and more treatment-related concerns than non-users, and about one in five wearable users experienced anxiety and consistently contacted their doctor in response to irregular rhythm notifications.²² This doesn’t mean monitoring causes net harm. For many patients, the reassurance of knowing their rhythm is being watched outweighs the anxiety. But it does mean that prescribing a monitoring device is not a purely technical decision. How the patient is counseled about what to expect from alerts, what constitutes a reason to call, and when to simply note something and move on can make the difference between a monitoring experience that empowers and one that generates chronic worry.

Where the Technology Is Heading

The trajectory of cardiac monitoring has been consistently toward longer recording periods, smaller devices, and smarter algorithms, and there’s no reason to think that trajectory will reverse. Patches are getting thinner. Implantable recorders are shrinking. AI interpretation is improving. The convergence of consumer wearables with clinical-grade monitoring is blurring the line between devices people choose to wear for fitness and devices their cardiologists recommend for medical reasons.

One emerging frontier is using ECG data for purposes that go well beyond arrhythmia detection. Researchers are training deep learning models to estimate things like heart pump function, blood potassium levels, and even the likelihood of developing heart failure years in the future, all from the electrical signal alone. Whether these applications prove reliable enough for clinical use remains to be seen, but the idea that a simple ECG might contain far more information than cardiologists have traditionally extracted from it is reshaping how the field thinks about monitoring’s potential. The limiting factor may end up being not what the technology can detect, but how effectively the medical system can act on the flood of information it produces.